Neuralink 2022: technical breakdown, key moments and clinical context
Published on 2 December 2022 ('Neuralink 2022', 0:50), this visual highlight reel recaps the hardware, cleanroom manufacturing, R1 surgical robot testing, and team milestones presented during the Fall 2022 Show and Tell event.
- Primary record: Official
@neuralinkvideo (8vAMt56p_j8) published on 2 Dec 2022 (duration0:50). - What it shows: Visual overview of Neuralink's late-2022 hardware state just months before FDA IDE clearance.
- Technical pathway: R1 surgical robot assembly → N1 hermetic package → preclinical testing highlights.
- Evidence boundary: 50-second music/visual montage from December 2022 prior to human trials.
Watch the official video record
Official upload from @neuralink (2 Dec 2022, 0:50).
Read verbatim official @neuralink YouTube description & caption provenance
Caption & verification basis: No caption track (music/visual clip; verified from video visuals and official description) (Official video visual inspection, official description metadata, and primary Neuralink disclosures).
Dye O / The Days We Remember / courtesy of www.epidemicsound.com
Technical pathway and evidence classification
R1 surgical robot assembly → N1 hermetic package → preclinical testing highlights
50-second music/visual montage from December 2022 prior to human trials.
Timestamped breakdown and key moments
| Timestamp | Segment / event | What happens in the segment |
|---|---|---|
00:00 | Hardware & cleanroom fabrication | Quick cuts of N1 implant packages, flexible threads, and R1 robotic heads. |
00:25 | Show and Tell stage & engineering team | Highlights from the 1 December 2022 presentation. |
What this video demonstrates—and what it does not establish
What this video demonstrates
- Visual overview of Neuralink's late-2022 hardware state just months before FDA IDE clearance.
Scope limits & what it does not establish
- 50-second montage without spoken narration; watch `YreDYmXTYi4` for the full 2h 48m technical presentation.
How this fits into Neuralink's broader clinical and hardware roadmap
This video sits inside the Clinical trials, keynotes & vision research research track on StonkBuilder's independent Neuralink hub. All Neuralink hardware (the N1 implant and R1 surgical robot) and clinical programs (PRIME NCT06429735, CONVOY, and VOICE NCT07224256) remain investigational and have not received FDA commercial marketing authorization. Read our full companion guide at Clinical trials, keynotes & vision research for cohort context.
Sources checked 30 Oct 2026
Sources and official records
- [1] Neuralink YouTube (2022-12-02): Neuralink 2022 ↗ · Verified 30 Oct 2026
- [2] Neuralink: Official YouTube Channel (@neuralink, UCLt4d8cACHzrVvAz9gtaARA) ↗ · Verified 30 Oct 2026
- [3] Neuralink: Official website and investigational device notice ↗ · Verified 30 Oct 2026
- [4] Neuralink: Clinical Trials and Patient Registry ↗ · Verified 30 Oct 2026
- [5] ClinicalTrials.gov: The PRIME Study (NCT06429735) ↗ · Verified 30 Oct 2026
- [6] Neuralink: Two Years of Telepathy (28 Jan 2026) ↗ · Verified 30 Oct 2026